Skip to content
10-K

Annual Report

Minerva Neurosciences, Inc. NERV

0000950170-25-026055

← back to feed
Filed
Feb 25, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 20, 2025 6.99M sh
Revenue FY 2024 · Dec 31, 2024 $0
Shares Diluted FY 2024 · Dec 31, 2023 6.51M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$14.78M
Cash And Equivalents FY 2024 · Dec 31, 2023 $40.91M
Current Liabilities FY 2024 · Dec 31, 2023 $3.34M
Total Liabilities FY 2024 · Dec 31, 2023 $85.36M
Current Assets FY 2024 · Dec 31, 2023 $42M
Total Assets FY 2024 · Dec 31, 2023 $56.9M
Eps Diluted FY 2024 · Dec 31, 2023 −$4.61
Eps Basic FY 2024 · Dec 31, 2023 −$4.61
Sga Expense FY 2024 · Dec 31, 2023 $10.41M
Rd Expense FY 2024 · Dec 31, 2023 $12.71M
Net Income FY 2024 · Dec 31, 2023 −$30.01M
Operating Income FY 2024 · Dec 31, 2023 −$23.12M
Stockholders Equity FY 2024 · Dec 31, 2022 −$20.02M